Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jana Collakova

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Biomedical Optics|August 6, 2015
Quantitative phase imaging through scattering media by means of coherence-controlled holographic microscopeVera Kollarova, Jana Collakova, Zbynek Dostal, et al.
Journal of Biomedical Optics|September 4, 2015
Coherence-controlled holographic microscopy enabled recognition of necrosis as the mechanism of cancer cells death after exposure to cytopathic turbid emulsionJana Collakova, Aneta Krizova, Vera Kollarova, et al.
Journal of Biomedical Optics|September 6, 2015
Dynamic phase differences based on quantitative phase imaging for the objective evaluation of cell behaviorAneta Krizova, Jana Collakova, Zbynek Dostal, et al.
Oncotarget|August 25, 2016
Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cellsJana Zemanova, Ondrej Hylse, Jana Collakova, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Biomedical Optics|August 6, 2015
Quantitative phase imaging through scattering media by means of coherence-controlled holographic microscopeVera Kollarova, Jana Collakova, Zbynek Dostal, et al.
Journal of Biomedical Optics|September 4, 2015
Coherence-controlled holographic microscopy enabled recognition of necrosis as the mechanism of cancer cells death after exposure to cytopathic turbid emulsionJana Collakova, Aneta Krizova, Vera Kollarova, et al.
Journal of Biomedical Optics|September 6, 2015
Dynamic phase differences based on quantitative phase imaging for the objective evaluation of cell behaviorAneta Krizova, Jana Collakova, Zbynek Dostal, et al.
Oncotarget|August 25, 2016
Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cellsJana Zemanova, Ondrej Hylse, Jana Collakova, et al.
Pageof 1